nodes	percent_of_prediction	percent_of_DWPC	metapath
Ifosfamide—Alkylating Activity—Thiotepa—sarcoma	0.294	0.556	CiPCiCtD
Ifosfamide—Alkylating Activity—Dacarbazine—sarcoma	0.235	0.444	CiPCiCtD
Ifosfamide—testicular cancer—sarcoma	0.156	0.511	CtDrD
Ifosfamide—germ cell cancer—sarcoma	0.149	0.489	CtDrD
Ifosfamide—CYP2B6—Thiotepa—sarcoma	0.0286	0.287	CbGbCtD
Ifosfamide—PTGS1—Etoposide—sarcoma	0.0102	0.102	CbGbCtD
Ifosfamide—CYP3A7-CYP3A51P—Vincristine—sarcoma	0.00889	0.0892	CbGbCtD
Ifosfamide—CYP3A7—Vincristine—sarcoma	0.00889	0.0892	CbGbCtD
Ifosfamide—CYP3A4—Thiotepa—sarcoma	0.00879	0.0882	CbGbCtD
Ifosfamide—CYP3A5—Vincristine—sarcoma	0.00667	0.0669	CbGbCtD
Ifosfamide—CYP3A5—Etoposide—sarcoma	0.00611	0.0613	CbGbCtD
Ifosfamide—CYP2C8—Etoposide—sarcoma	0.00587	0.0589	CbGbCtD
Ifosfamide—CYP2B6—Doxorubicin—sarcoma	0.00529	0.0531	CbGbCtD
Ifosfamide—CYP3A4—Mitoxantrone—sarcoma	0.00378	0.0379	CbGbCtD
Ifosfamide—CYP3A4—Vincristine—sarcoma	0.0026	0.0261	CbGbCtD
Ifosfamide—CYP3A4—Etoposide—sarcoma	0.00238	0.0239	CbGbCtD
Ifosfamide—CYP3A4—Doxorubicin—sarcoma	0.00162	0.0163	CbGbCtD
Ifosfamide—Toxic epidermal necrolysis—Epirubicin—sarcoma	3e-05	0.000459	CcSEcCtD
Ifosfamide—Hypersensitivity—Thiotepa—sarcoma	2.99e-05	0.000459	CcSEcCtD
Ifosfamide—Hypersensitivity—Dactinomycin—sarcoma	2.97e-05	0.000455	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Vincristine—sarcoma	2.94e-05	0.000451	CcSEcCtD
Ifosfamide—Confusional state—Etoposide—sarcoma	2.94e-05	0.000451	CcSEcCtD
Ifosfamide—Cardiac arrest—Doxorubicin—sarcoma	2.93e-05	0.000449	CcSEcCtD
Ifosfamide—Anaphylactic shock—Etoposide—sarcoma	2.92e-05	0.000447	CcSEcCtD
Ifosfamide—Asthenia—Thiotepa—sarcoma	2.91e-05	0.000447	CcSEcCtD
Ifosfamide—Infection—Etoposide—sarcoma	2.9e-05	0.000444	CcSEcCtD
Ifosfamide—Asthenia—Dactinomycin—sarcoma	2.89e-05	0.000443	CcSEcCtD
Ifosfamide—Feeling abnormal—Mitoxantrone—sarcoma	2.89e-05	0.000443	CcSEcCtD
Ifosfamide—Blood creatinine increased—Doxorubicin—sarcoma	2.88e-05	0.000442	CcSEcCtD
Ifosfamide—Pruritus—Thiotepa—sarcoma	2.87e-05	0.00044	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Mitoxantrone—sarcoma	2.87e-05	0.000439	CcSEcCtD
Ifosfamide—Thrombocytopenia—Etoposide—sarcoma	2.86e-05	0.000438	CcSEcCtD
Ifosfamide—Body temperature increased—Vincristine—sarcoma	2.85e-05	0.000436	CcSEcCtD
Ifosfamide—Abdominal pain—Vincristine—sarcoma	2.85e-05	0.000436	CcSEcCtD
Ifosfamide—Skin disorder—Etoposide—sarcoma	2.83e-05	0.000434	CcSEcCtD
Ifosfamide—Hyperhidrosis—Etoposide—sarcoma	2.82e-05	0.000432	CcSEcCtD
Ifosfamide—Pancreatitis—Epirubicin—sarcoma	2.82e-05	0.000432	CcSEcCtD
Ifosfamide—Hypokalaemia—Doxorubicin—sarcoma	2.8e-05	0.000429	CcSEcCtD
Ifosfamide—Angina pectoris—Epirubicin—sarcoma	2.8e-05	0.000429	CcSEcCtD
Ifosfamide—Urticaria—Mitoxantrone—sarcoma	2.79e-05	0.000427	CcSEcCtD
Ifosfamide—Breast disorder—Doxorubicin—sarcoma	2.78e-05	0.000426	CcSEcCtD
Ifosfamide—Anorexia—Etoposide—sarcoma	2.78e-05	0.000426	CcSEcCtD
Ifosfamide—Diarrhoea—Thiotepa—sarcoma	2.78e-05	0.000426	CcSEcCtD
Ifosfamide—Abdominal pain—Mitoxantrone—sarcoma	2.77e-05	0.000425	CcSEcCtD
Ifosfamide—Body temperature increased—Mitoxantrone—sarcoma	2.77e-05	0.000425	CcSEcCtD
Ifosfamide—Toxic epidermal necrolysis—Doxorubicin—sarcoma	2.77e-05	0.000425	CcSEcCtD
Ifosfamide—Diarrhoea—Dactinomycin—sarcoma	2.76e-05	0.000423	CcSEcCtD
Ifosfamide—Pancytopenia—Epirubicin—sarcoma	2.73e-05	0.000418	CcSEcCtD
Ifosfamide—Hypotension—Etoposide—sarcoma	2.73e-05	0.000418	CcSEcCtD
Ifosfamide—Dysuria—Epirubicin—sarcoma	2.69e-05	0.000412	CcSEcCtD
Ifosfamide—Dizziness—Thiotepa—sarcoma	2.68e-05	0.000412	CcSEcCtD
Ifosfamide—Pollakiuria—Epirubicin—sarcoma	2.66e-05	0.000407	CcSEcCtD
Ifosfamide—Hypersensitivity—Vincristine—sarcoma	2.65e-05	0.000407	CcSEcCtD
Ifosfamide—Paraesthesia—Etoposide—sarcoma	2.62e-05	0.000401	CcSEcCtD
Ifosfamide—Pancreatitis—Doxorubicin—sarcoma	2.61e-05	0.0004	CcSEcCtD
Ifosfamide—Dyspnoea—Etoposide—sarcoma	2.6e-05	0.000399	CcSEcCtD
Ifosfamide—Hyperglycaemia—Epirubicin—sarcoma	2.59e-05	0.000398	CcSEcCtD
Ifosfamide—Somnolence—Etoposide—sarcoma	2.59e-05	0.000397	CcSEcCtD
Ifosfamide—Angina pectoris—Doxorubicin—sarcoma	2.59e-05	0.000397	CcSEcCtD
Ifosfamide—Hypersensitivity—Mitoxantrone—sarcoma	2.58e-05	0.000396	CcSEcCtD
Ifosfamide—Asthenia—Vincristine—sarcoma	2.58e-05	0.000396	CcSEcCtD
Ifosfamide—Vomiting—Thiotepa—sarcoma	2.58e-05	0.000396	CcSEcCtD
Ifosfamide—Pneumonia—Epirubicin—sarcoma	2.58e-05	0.000395	CcSEcCtD
Ifosfamide—Infestation—Epirubicin—sarcoma	2.56e-05	0.000393	CcSEcCtD
Ifosfamide—Infestation NOS—Epirubicin—sarcoma	2.56e-05	0.000393	CcSEcCtD
Ifosfamide—Vomiting—Dactinomycin—sarcoma	2.56e-05	0.000393	CcSEcCtD
Ifosfamide—Rash—Thiotepa—sarcoma	2.56e-05	0.000392	CcSEcCtD
Ifosfamide—Dermatitis—Thiotepa—sarcoma	2.56e-05	0.000392	CcSEcCtD
Ifosfamide—Stevens-Johnson syndrome—Epirubicin—sarcoma	2.54e-05	0.00039	CcSEcCtD
Ifosfamide—Rash—Dactinomycin—sarcoma	2.54e-05	0.000389	CcSEcCtD
Ifosfamide—Decreased appetite—Etoposide—sarcoma	2.54e-05	0.000389	CcSEcCtD
Ifosfamide—Pancytopenia—Doxorubicin—sarcoma	2.53e-05	0.000387	CcSEcCtD
Ifosfamide—Renal failure—Epirubicin—sarcoma	2.52e-05	0.000386	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Etoposide—sarcoma	2.52e-05	0.000386	CcSEcCtD
Ifosfamide—Asthenia—Mitoxantrone—sarcoma	2.52e-05	0.000386	CcSEcCtD
Ifosfamide—Fatigue—Etoposide—sarcoma	2.51e-05	0.000385	CcSEcCtD
Ifosfamide—Neuropathy peripheral—Epirubicin—sarcoma	2.51e-05	0.000385	CcSEcCtD
Ifosfamide—Stomatitis—Epirubicin—sarcoma	2.5e-05	0.000383	CcSEcCtD
Ifosfamide—Pain—Etoposide—sarcoma	2.49e-05	0.000382	CcSEcCtD
Ifosfamide—Constipation—Etoposide—sarcoma	2.49e-05	0.000382	CcSEcCtD
Ifosfamide—Conjunctivitis—Epirubicin—sarcoma	2.49e-05	0.000382	CcSEcCtD
Ifosfamide—Dysuria—Doxorubicin—sarcoma	2.49e-05	0.000381	CcSEcCtD
Ifosfamide—Diarrhoea—Vincristine—sarcoma	2.46e-05	0.000378	CcSEcCtD
Ifosfamide—Pollakiuria—Doxorubicin—sarcoma	2.46e-05	0.000377	CcSEcCtD
Ifosfamide—Haematuria—Epirubicin—sarcoma	2.44e-05	0.000375	CcSEcCtD
Ifosfamide—Hepatobiliary disease—Epirubicin—sarcoma	2.42e-05	0.000372	CcSEcCtD
Ifosfamide—Nausea—Thiotepa—sarcoma	2.41e-05	0.00037	CcSEcCtD
Ifosfamide—Feeling abnormal—Etoposide—sarcoma	2.4e-05	0.000368	CcSEcCtD
Ifosfamide—Hyperglycaemia—Doxorubicin—sarcoma	2.4e-05	0.000368	CcSEcCtD
Ifosfamide—Diarrhoea—Mitoxantrone—sarcoma	2.4e-05	0.000368	CcSEcCtD
Ifosfamide—Nausea—Dactinomycin—sarcoma	2.39e-05	0.000367	CcSEcCtD
Ifosfamide—Agranulocytosis—Epirubicin—sarcoma	2.39e-05	0.000367	CcSEcCtD
Ifosfamide—Pneumonia—Doxorubicin—sarcoma	2.39e-05	0.000366	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Etoposide—sarcoma	2.38e-05	0.000366	CcSEcCtD
Ifosfamide—Dizziness—Vincristine—sarcoma	2.38e-05	0.000365	CcSEcCtD
Ifosfamide—Infestation NOS—Doxorubicin—sarcoma	2.37e-05	0.000364	CcSEcCtD
Ifosfamide—Infestation—Doxorubicin—sarcoma	2.37e-05	0.000364	CcSEcCtD
Ifosfamide—Stevens-Johnson syndrome—Doxorubicin—sarcoma	2.35e-05	0.00036	CcSEcCtD
Ifosfamide—Bradycardia—Epirubicin—sarcoma	2.34e-05	0.000359	CcSEcCtD
Ifosfamide—Renal failure—Doxorubicin—sarcoma	2.33e-05	0.000357	CcSEcCtD
Ifosfamide—Neuropathy peripheral—Doxorubicin—sarcoma	2.32e-05	0.000356	CcSEcCtD
Ifosfamide—Urticaria—Etoposide—sarcoma	2.32e-05	0.000355	CcSEcCtD
Ifosfamide—Haemoglobin—Epirubicin—sarcoma	2.31e-05	0.000355	CcSEcCtD
Ifosfamide—Stomatitis—Doxorubicin—sarcoma	2.31e-05	0.000354	CcSEcCtD
Ifosfamide—Abdominal pain—Etoposide—sarcoma	2.31e-05	0.000353	CcSEcCtD
Ifosfamide—Body temperature increased—Etoposide—sarcoma	2.31e-05	0.000353	CcSEcCtD
Ifosfamide—Conjunctivitis—Doxorubicin—sarcoma	2.31e-05	0.000353	CcSEcCtD
Ifosfamide—Haemorrhage—Epirubicin—sarcoma	2.3e-05	0.000353	CcSEcCtD
Ifosfamide—Hepatitis—Epirubicin—sarcoma	2.3e-05	0.000353	CcSEcCtD
Ifosfamide—Vomiting—Vincristine—sarcoma	2.29e-05	0.000351	CcSEcCtD
Ifosfamide—Urinary tract disorder—Epirubicin—sarcoma	2.27e-05	0.000348	CcSEcCtD
Ifosfamide—Rash—Vincristine—sarcoma	2.27e-05	0.000348	CcSEcCtD
Ifosfamide—Dermatitis—Vincristine—sarcoma	2.27e-05	0.000348	CcSEcCtD
Ifosfamide—Haematuria—Doxorubicin—sarcoma	2.26e-05	0.000347	CcSEcCtD
Ifosfamide—Connective tissue disorder—Epirubicin—sarcoma	2.26e-05	0.000347	CcSEcCtD
Ifosfamide—Urethral disorder—Epirubicin—sarcoma	2.26e-05	0.000346	CcSEcCtD
Ifosfamide—Hepatobiliary disease—Doxorubicin—sarcoma	2.24e-05	0.000344	CcSEcCtD
Ifosfamide—Vomiting—Mitoxantrone—sarcoma	2.23e-05	0.000342	CcSEcCtD
Ifosfamide—Visual impairment—Epirubicin—sarcoma	2.22e-05	0.00034	CcSEcCtD
Ifosfamide—Agranulocytosis—Doxorubicin—sarcoma	2.21e-05	0.000339	CcSEcCtD
Ifosfamide—Rash—Mitoxantrone—sarcoma	2.21e-05	0.000339	CcSEcCtD
Ifosfamide—Dermatitis—Mitoxantrone—sarcoma	2.21e-05	0.000339	CcSEcCtD
Ifosfamide—Erythema multiforme—Epirubicin—sarcoma	2.18e-05	0.000333	CcSEcCtD
Ifosfamide—Bradycardia—Doxorubicin—sarcoma	2.17e-05	0.000332	CcSEcCtD
Ifosfamide—Eye disorder—Epirubicin—sarcoma	2.15e-05	0.00033	CcSEcCtD
Ifosfamide—Hypersensitivity—Etoposide—sarcoma	2.15e-05	0.000329	CcSEcCtD
Ifosfamide—Tinnitus—Epirubicin—sarcoma	2.15e-05	0.000329	CcSEcCtD
Ifosfamide—Haemoglobin—Doxorubicin—sarcoma	2.14e-05	0.000328	CcSEcCtD
Ifosfamide—Nausea—Vincristine—sarcoma	2.14e-05	0.000328	CcSEcCtD
Ifosfamide—Flushing—Epirubicin—sarcoma	2.14e-05	0.000327	CcSEcCtD
Ifosfamide—Cardiac disorder—Epirubicin—sarcoma	2.14e-05	0.000327	CcSEcCtD
Ifosfamide—Hepatitis—Doxorubicin—sarcoma	2.13e-05	0.000326	CcSEcCtD
Ifosfamide—Haemorrhage—Doxorubicin—sarcoma	2.13e-05	0.000326	CcSEcCtD
Ifosfamide—Urinary tract disorder—Doxorubicin—sarcoma	2.1e-05	0.000322	CcSEcCtD
Ifosfamide—Asthenia—Etoposide—sarcoma	2.09e-05	0.000321	CcSEcCtD
Ifosfamide—Connective tissue disorder—Doxorubicin—sarcoma	2.09e-05	0.000321	CcSEcCtD
Ifosfamide—Angiopathy—Epirubicin—sarcoma	2.09e-05	0.00032	CcSEcCtD
Ifosfamide—Urethral disorder—Doxorubicin—sarcoma	2.09e-05	0.00032	CcSEcCtD
Ifosfamide—Nausea—Mitoxantrone—sarcoma	2.08e-05	0.000319	CcSEcCtD
Ifosfamide—Immune system disorder—Epirubicin—sarcoma	2.08e-05	0.000319	CcSEcCtD
Ifosfamide—Mediastinal disorder—Epirubicin—sarcoma	2.07e-05	0.000318	CcSEcCtD
Ifosfamide—Chills—Epirubicin—sarcoma	2.06e-05	0.000316	CcSEcCtD
Ifosfamide—Pruritus—Etoposide—sarcoma	2.06e-05	0.000316	CcSEcCtD
Ifosfamide—Arrhythmia—Epirubicin—sarcoma	2.06e-05	0.000315	CcSEcCtD
Ifosfamide—Visual impairment—Doxorubicin—sarcoma	2.05e-05	0.000315	CcSEcCtD
Ifosfamide—Alopecia—Epirubicin—sarcoma	2.03e-05	0.000312	CcSEcCtD
Ifosfamide—Mental disorder—Epirubicin—sarcoma	2.02e-05	0.000309	CcSEcCtD
Ifosfamide—Erythema multiforme—Doxorubicin—sarcoma	2.01e-05	0.000309	CcSEcCtD
Ifosfamide—Malnutrition—Epirubicin—sarcoma	2e-05	0.000307	CcSEcCtD
Ifosfamide—Erythema—Epirubicin—sarcoma	2e-05	0.000307	CcSEcCtD
Ifosfamide—Diarrhoea—Etoposide—sarcoma	2e-05	0.000306	CcSEcCtD
Ifosfamide—Eye disorder—Doxorubicin—sarcoma	1.99e-05	0.000305	CcSEcCtD
Ifosfamide—Tinnitus—Doxorubicin—sarcoma	1.99e-05	0.000304	CcSEcCtD
Ifosfamide—Flushing—Doxorubicin—sarcoma	1.98e-05	0.000303	CcSEcCtD
Ifosfamide—Cardiac disorder—Doxorubicin—sarcoma	1.98e-05	0.000303	CcSEcCtD
Ifosfamide—Angiopathy—Doxorubicin—sarcoma	1.93e-05	0.000296	CcSEcCtD
Ifosfamide—Dizziness—Etoposide—sarcoma	1.93e-05	0.000296	CcSEcCtD
Ifosfamide—Immune system disorder—Doxorubicin—sarcoma	1.92e-05	0.000295	CcSEcCtD
Ifosfamide—Mediastinal disorder—Doxorubicin—sarcoma	1.92e-05	0.000294	CcSEcCtD
Ifosfamide—Chills—Doxorubicin—sarcoma	1.91e-05	0.000293	CcSEcCtD
Ifosfamide—Arrhythmia—Doxorubicin—sarcoma	1.9e-05	0.000292	CcSEcCtD
Ifosfamide—Vision blurred—Epirubicin—sarcoma	1.89e-05	0.000289	CcSEcCtD
Ifosfamide—Alopecia—Doxorubicin—sarcoma	1.88e-05	0.000288	CcSEcCtD
Ifosfamide—Mental disorder—Doxorubicin—sarcoma	1.87e-05	0.000286	CcSEcCtD
Ifosfamide—Ill-defined disorder—Epirubicin—sarcoma	1.86e-05	0.000285	CcSEcCtD
Ifosfamide—Vomiting—Etoposide—sarcoma	1.85e-05	0.000284	CcSEcCtD
Ifosfamide—Erythema—Doxorubicin—sarcoma	1.85e-05	0.000284	CcSEcCtD
Ifosfamide—Malnutrition—Doxorubicin—sarcoma	1.85e-05	0.000284	CcSEcCtD
Ifosfamide—Anaemia—Epirubicin—sarcoma	1.85e-05	0.000284	CcSEcCtD
Ifosfamide—Agitation—Epirubicin—sarcoma	1.84e-05	0.000282	CcSEcCtD
Ifosfamide—Rash—Etoposide—sarcoma	1.84e-05	0.000282	CcSEcCtD
Ifosfamide—Dermatitis—Etoposide—sarcoma	1.84e-05	0.000282	CcSEcCtD
Ifosfamide—Malaise—Epirubicin—sarcoma	1.81e-05	0.000277	CcSEcCtD
Ifosfamide—Vertigo—Epirubicin—sarcoma	1.8e-05	0.000276	CcSEcCtD
Ifosfamide—Leukopenia—Epirubicin—sarcoma	1.79e-05	0.000275	CcSEcCtD
Ifosfamide—Palpitations—Epirubicin—sarcoma	1.77e-05	0.000271	CcSEcCtD
Ifosfamide—Cough—Epirubicin—sarcoma	1.75e-05	0.000268	CcSEcCtD
Ifosfamide—Vision blurred—Doxorubicin—sarcoma	1.75e-05	0.000268	CcSEcCtD
Ifosfamide—Convulsion—Epirubicin—sarcoma	1.74e-05	0.000266	CcSEcCtD
Ifosfamide—Nausea—Etoposide—sarcoma	1.73e-05	0.000266	CcSEcCtD
Ifosfamide—Hypertension—Epirubicin—sarcoma	1.73e-05	0.000265	CcSEcCtD
Ifosfamide—Ill-defined disorder—Doxorubicin—sarcoma	1.72e-05	0.000264	CcSEcCtD
Ifosfamide—Anaemia—Doxorubicin—sarcoma	1.71e-05	0.000263	CcSEcCtD
Ifosfamide—Chest pain—Epirubicin—sarcoma	1.71e-05	0.000261	CcSEcCtD
Ifosfamide—Myalgia—Epirubicin—sarcoma	1.71e-05	0.000261	CcSEcCtD
Ifosfamide—Arthralgia—Epirubicin—sarcoma	1.71e-05	0.000261	CcSEcCtD
Ifosfamide—Agitation—Doxorubicin—sarcoma	1.7e-05	0.000261	CcSEcCtD
Ifosfamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	1.69e-05	0.00026	CcSEcCtD
Ifosfamide—Discomfort—Epirubicin—sarcoma	1.68e-05	0.000258	CcSEcCtD
Ifosfamide—Malaise—Doxorubicin—sarcoma	1.67e-05	0.000256	CcSEcCtD
Ifosfamide—Vertigo—Doxorubicin—sarcoma	1.67e-05	0.000255	CcSEcCtD
Ifosfamide—Leukopenia—Doxorubicin—sarcoma	1.66e-05	0.000254	CcSEcCtD
Ifosfamide—Confusional state—Epirubicin—sarcoma	1.65e-05	0.000253	CcSEcCtD
Ifosfamide—Palpitations—Doxorubicin—sarcoma	1.64e-05	0.000251	CcSEcCtD
Ifosfamide—Anaphylactic shock—Epirubicin—sarcoma	1.63e-05	0.000251	CcSEcCtD
Ifosfamide—Oedema—Epirubicin—sarcoma	1.63e-05	0.000251	CcSEcCtD
Ifosfamide—Infection—Epirubicin—sarcoma	1.62e-05	0.000249	CcSEcCtD
Ifosfamide—Cough—Doxorubicin—sarcoma	1.62e-05	0.000248	CcSEcCtD
Ifosfamide—Convulsion—Doxorubicin—sarcoma	1.61e-05	0.000246	CcSEcCtD
Ifosfamide—Nervous system disorder—Epirubicin—sarcoma	1.6e-05	0.000246	CcSEcCtD
Ifosfamide—Thrombocytopenia—Epirubicin—sarcoma	1.6e-05	0.000245	CcSEcCtD
Ifosfamide—Hypertension—Doxorubicin—sarcoma	1.6e-05	0.000245	CcSEcCtD
Ifosfamide—Skin disorder—Epirubicin—sarcoma	1.59e-05	0.000243	CcSEcCtD
Ifosfamide—Hyperhidrosis—Epirubicin—sarcoma	1.58e-05	0.000242	CcSEcCtD
Ifosfamide—Arthralgia—Doxorubicin—sarcoma	1.58e-05	0.000242	CcSEcCtD
Ifosfamide—Chest pain—Doxorubicin—sarcoma	1.58e-05	0.000242	CcSEcCtD
Ifosfamide—Myalgia—Doxorubicin—sarcoma	1.58e-05	0.000242	CcSEcCtD
Ifosfamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	1.57e-05	0.00024	CcSEcCtD
Ifosfamide—Discomfort—Doxorubicin—sarcoma	1.56e-05	0.000239	CcSEcCtD
Ifosfamide—Anorexia—Epirubicin—sarcoma	1.56e-05	0.000239	CcSEcCtD
Ifosfamide—Hypotension—Epirubicin—sarcoma	1.53e-05	0.000234	CcSEcCtD
Ifosfamide—Confusional state—Doxorubicin—sarcoma	1.53e-05	0.000234	CcSEcCtD
Ifosfamide—Anaphylactic shock—Doxorubicin—sarcoma	1.51e-05	0.000232	CcSEcCtD
Ifosfamide—Oedema—Doxorubicin—sarcoma	1.51e-05	0.000232	CcSEcCtD
Ifosfamide—Infection—Doxorubicin—sarcoma	1.5e-05	0.00023	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Epirubicin—sarcoma	1.49e-05	0.000228	CcSEcCtD
Ifosfamide—Nervous system disorder—Doxorubicin—sarcoma	1.48e-05	0.000227	CcSEcCtD
Ifosfamide—Thrombocytopenia—Doxorubicin—sarcoma	1.48e-05	0.000227	CcSEcCtD
Ifosfamide—Skin disorder—Doxorubicin—sarcoma	1.47e-05	0.000225	CcSEcCtD
Ifosfamide—Paraesthesia—Epirubicin—sarcoma	1.47e-05	0.000225	CcSEcCtD
Ifosfamide—Hyperhidrosis—Doxorubicin—sarcoma	1.46e-05	0.000224	CcSEcCtD
Ifosfamide—Dyspnoea—Epirubicin—sarcoma	1.46e-05	0.000223	CcSEcCtD
Ifosfamide—Somnolence—Epirubicin—sarcoma	1.45e-05	0.000223	CcSEcCtD
Ifosfamide—Anorexia—Doxorubicin—sarcoma	1.44e-05	0.000221	CcSEcCtD
Ifosfamide—Decreased appetite—Epirubicin—sarcoma	1.42e-05	0.000218	CcSEcCtD
Ifosfamide—Hypotension—Doxorubicin—sarcoma	1.41e-05	0.000217	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Epirubicin—sarcoma	1.41e-05	0.000216	CcSEcCtD
Ifosfamide—Fatigue—Epirubicin—sarcoma	1.41e-05	0.000216	CcSEcCtD
Ifosfamide—Pain—Epirubicin—sarcoma	1.4e-05	0.000214	CcSEcCtD
Ifosfamide—Constipation—Epirubicin—sarcoma	1.4e-05	0.000214	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Doxorubicin—sarcoma	1.38e-05	0.000211	CcSEcCtD
Ifosfamide—Paraesthesia—Doxorubicin—sarcoma	1.36e-05	0.000208	CcSEcCtD
Ifosfamide—Dyspnoea—Doxorubicin—sarcoma	1.35e-05	0.000207	CcSEcCtD
Ifosfamide—Feeling abnormal—Epirubicin—sarcoma	1.35e-05	0.000206	CcSEcCtD
Ifosfamide—Somnolence—Doxorubicin—sarcoma	1.34e-05	0.000206	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Epirubicin—sarcoma	1.34e-05	0.000205	CcSEcCtD
Ifosfamide—Decreased appetite—Doxorubicin—sarcoma	1.31e-05	0.000202	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Doxorubicin—sarcoma	1.31e-05	0.0002	CcSEcCtD
Ifosfamide—Fatigue—Doxorubicin—sarcoma	1.3e-05	0.0002	CcSEcCtD
Ifosfamide—Urticaria—Epirubicin—sarcoma	1.3e-05	0.000199	CcSEcCtD
Ifosfamide—Constipation—Doxorubicin—sarcoma	1.29e-05	0.000198	CcSEcCtD
Ifosfamide—Pain—Doxorubicin—sarcoma	1.29e-05	0.000198	CcSEcCtD
Ifosfamide—Abdominal pain—Epirubicin—sarcoma	1.29e-05	0.000198	CcSEcCtD
Ifosfamide—Body temperature increased—Epirubicin—sarcoma	1.29e-05	0.000198	CcSEcCtD
Ifosfamide—Feeling abnormal—Doxorubicin—sarcoma	1.25e-05	0.000191	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Doxorubicin—sarcoma	1.24e-05	0.00019	CcSEcCtD
Ifosfamide—Hypersensitivity—Epirubicin—sarcoma	1.2e-05	0.000185	CcSEcCtD
Ifosfamide—Urticaria—Doxorubicin—sarcoma	1.2e-05	0.000184	CcSEcCtD
Ifosfamide—Abdominal pain—Doxorubicin—sarcoma	1.2e-05	0.000183	CcSEcCtD
Ifosfamide—Body temperature increased—Doxorubicin—sarcoma	1.2e-05	0.000183	CcSEcCtD
Ifosfamide—Asthenia—Epirubicin—sarcoma	1.17e-05	0.00018	CcSEcCtD
Ifosfamide—Pruritus—Epirubicin—sarcoma	1.16e-05	0.000177	CcSEcCtD
Ifosfamide—Diarrhoea—Epirubicin—sarcoma	1.12e-05	0.000171	CcSEcCtD
Ifosfamide—Hypersensitivity—Doxorubicin—sarcoma	1.11e-05	0.000171	CcSEcCtD
Ifosfamide—Asthenia—Doxorubicin—sarcoma	1.09e-05	0.000166	CcSEcCtD
Ifosfamide—Dizziness—Epirubicin—sarcoma	1.08e-05	0.000166	CcSEcCtD
Ifosfamide—Pruritus—Doxorubicin—sarcoma	1.07e-05	0.000164	CcSEcCtD
Ifosfamide—Vomiting—Epirubicin—sarcoma	1.04e-05	0.000159	CcSEcCtD
Ifosfamide—Diarrhoea—Doxorubicin—sarcoma	1.03e-05	0.000159	CcSEcCtD
Ifosfamide—Rash—Epirubicin—sarcoma	1.03e-05	0.000158	CcSEcCtD
Ifosfamide—Dermatitis—Epirubicin—sarcoma	1.03e-05	0.000158	CcSEcCtD
Ifosfamide—Dizziness—Doxorubicin—sarcoma	1e-05	0.000153	CcSEcCtD
Ifosfamide—Nausea—Epirubicin—sarcoma	9.71e-06	0.000149	CcSEcCtD
Ifosfamide—Vomiting—Doxorubicin—sarcoma	9.62e-06	0.000147	CcSEcCtD
Ifosfamide—Rash—Doxorubicin—sarcoma	9.54e-06	0.000146	CcSEcCtD
Ifosfamide—Dermatitis—Doxorubicin—sarcoma	9.53e-06	0.000146	CcSEcCtD
Ifosfamide—Nausea—Doxorubicin—sarcoma	8.99e-06	0.000138	CcSEcCtD
